Clot Treatment Trials Should Be Tailored to Type of Clot: EMA

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency is revising the way drugmakers conduct studies of drugs to treat blood clots, for the first time separating out the clinical requirements for different types of clots.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00